Home » Drug Information » FDA Approved Drugs » 1996
Medical Areas: Psychiatry/Psychology
View By:YearCompanyConditionsTherapeutic AreasDrug Names
Nicotrol transdermal patch
The following drug information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: McNeil Consumer Products
Approval Status: Approved July 1996
Treatment Area: smoking cessation
Nicotrol has been approved for marketing as the first nicotine
patch available for sale directly to consumers without a
prescription. Nicotrol will be available in a single 15 mg
strength, and should be used daily for six weeks.
Side effects from the patch are usually mild, with the most
common being skin rash where the patch is applied; such reactions
usually can be controlled by changing the site of application each
Nicotrol is not recommended for everyone. Pregnant and nursing
women, individuals with heart disease, those with high blood
pressure, or those who have suffered a recent heart attack should
check with their doctors before using this product.
According to the American Cancer Society, an estimated 46
million adults continue to smoke despite the health risks
associated with it. Cigarette smoking is a major cause of heart
disease, lung cancer, and emphysema, as well as other diseases.
Annual smoking-related deaths are estimated to be 419,000 in the
United States, with three million deaths occurring worldwide.